Rev-Eyes - General Information
Rev-Eyes (U.S. trade name Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination. [Wikipedia]
Pharmacology of Rev-Eyes
Rev-Eyes is an alpha-adrenergic blocking agent. It produces miosis by blocking the alpha-adrenergic receptors on the dilator muscle of the iris. Rev-Eyes produces no significant action on ciliary muscle contraction and thus, there are no changes in the depth of the anterior chamber of the thickness of the lens. It does not alter the IOP either in normal eyes or in eyes with elevated IOP. The rate of pupillary constriction may be slightly slower in clients with brown irises than in clients with blue or green irises.
Rev-Eyes for patients
Even after using this medicine, you may have blurred vision or other vision problems. If any of these occur, do not drive, use machines, or do anything else that could be dangerous if you are not able to see well. This medicine may cause your eyes to become more sensitive to light than they are normally. Wearing sunglasses and avoiding too much exposure to bright light may help lessen the discomfort.
Miotics are contraindicated where constriction is undesirable; such as acute iritis, and in those subjects showing hypersensitivity to any component of this preparation.
Additional information about Rev-Eyes
Rev-Eyes Indication: Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.
Mechanism Of Action: Rev-Eyes acts through blocking the alpha1-adrenergic receptors in smooth muscle. It produces miosis through an effect on the dilator muscle of the iris and does not have any significant activity on ciliary muscle contraction and, therefore does not induce a significant change in the anterior chamber depth or the thickness of the lens.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Dapiprazole
Synonyms: Not Available
Drug Category: Adrenergic alpha-Antagonists; Antimydriatics; Ophthalmologicals
Drug Type: Small Molecule; Approved
Absorption: Systemic absorption is negligible.
Toxicity (Overdose): Oral LD50 is 1189-2100 mg/kg in mice, rats and rabbits.
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Rev-Eyes: Solution / drops Ophthalmic
Chemical IUPAC Name: 3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,5-a]pyridine
Chemical Formula: C19H27N5
Dapiprazole on Wikipedia: https://en.wikipedia.org/wiki/Dapiprazole
Organisms Affected: Humans and other mammals